Sanofi’s Sarclisa combo approved in China for multiple myeloma
Pharmaceutical Technology
FEBRUARY 3, 2025
Sanofi has received Chinas NMPA approval for the use of Sarclisa, combined with a standard-of-care regimen, for treating adults with NDMM.
Pharmaceutical Technology
FEBRUARY 3, 2025
Sanofi has received Chinas NMPA approval for the use of Sarclisa, combined with a standard-of-care regimen, for treating adults with NDMM.
PharmaTimes
FEBRUARY 3, 2025
Funding led by new investors FSG and EIC Fund
Pharmaceutical Technology
FEBRUARY 3, 2025
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
PharmaVoice
FEBRUARY 3, 2025
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are coming through the pipes if it does.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmaTimes
FEBRUARY 3, 2025
Positive opinion issued for marketing authorisation extension
MedCity News
FEBRUARY 3, 2025
For every life lost, the ripple effects continue outward, often creating distinct suicide clusters, which account for as many as 5% of all suicides. Breaking this cycle is essential to preventing thousands of tragedies each year. The post Suicide Is Contagious appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
FEBRUARY 3, 2025
The colon cancer BRAFF mutation study is one of the first to be initiated under the FDAs Project FrontRunner.
Pharmaceutical Commerce
FEBRUARY 3, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
FEBRUARY 3, 2025
L'Oral is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.
Pharmaceutical Commerce
FEBRUARY 3, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, describes the highlights of a recent pharma supply chain security and visibility report that his company released.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Technology
FEBRUARY 3, 2025
AdvanCells lead candidate ADVC001 is being evaluated in a Phase I/II dose escalation clinical trial.
Pharmacy Times
FEBRUARY 3, 2025
Rising seasonal viruses and emerging concerns emphasize the need for public awareness and prevention.
Pharmaceutical Technology
FEBRUARY 3, 2025
The FDA has granted approval for Celltrion's Avtozma in both IV and SC formulations as Actemra biosimilar for treating several conditions.
pharmaphorum
FEBRUARY 3, 2025
Bayer has filed its mineralocorticoid receptor antagonist finerenone as a treatment heart failure in the EU, but can it meet blockbuster sales hopes?
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
FEBRUARY 3, 2025
The EC has authorised the use of ViiV Healthcares Vocabria plus Rekambys from J&J for treating adolescents with HIV-1.
Pharmacy Times
FEBRUARY 3, 2025
The phase 1b/2a results show the potential of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist.
Pharmaceutical Technology
FEBRUARY 3, 2025
On World Cancer Day, tackling barriers in equitable care requires not only policy action, but a shift in how cancer is examined.
PharmaTech
FEBRUARY 3, 2025
While FMS has specialized in the design, installation, and maintenance of environmental monitoring systems, Trescals focus has been on calibration and metrology services.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Pharmaceutical Technology
FEBRUARY 3, 2025
On World Cancer Day, tackling barriers in equitable cancer care requires not only policy action, but a shift in how cancer is examined.
PharmExec
FEBRUARY 3, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaVoice
FEBRUARY 3, 2025
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?
PharmExec
FEBRUARY 3, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmacy Times
FEBRUARY 3, 2025
Topical, targeted drug delivery increases drug concentrations at the desired site while also reducing toxicity and unwanted adverse effects.
PharmExec
FEBRUARY 3, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
FEBRUARY 3, 2025
Many patients do not attain sufficient disease control with inhaled corticosteroids in combination with long-acting -2 agonists and remain vulnerable to exacerbations.
pharmaphorum
FEBRUARY 3, 2025
It's been reported that the UK government made an offer of 78m in funding for AstraZeneca's abandoned 450 million vaccine facility in Speke
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
Pharmacy Times
FEBRUARY 3, 2025
Antiviral treatments can accelerate healing and reduce complications.
Progressive Medical
FEBRUARY 3, 2025
You must be a registered user to view this information. The post Monthly Employee Portal Updates | January 2025 appeared first on Progressive Medical, Inc.
Pharmacy Times
FEBRUARY 3, 2025
Three experts from UPMC Health Plan highlight the importance of treating patients physical, mental, and social health when managing diabetes, rather than the disease alone.
MedCity News
FEBRUARY 3, 2025
The shift to a VBC model represents more than an evolution in healthcare delivery – it demands a fundamental redesign of our healthcare system and the economic models to support it. The post Unlocking Success in Value-Based Care: Why Focusing on Specialized Populations is Key appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Let's personalize your content